Role of lncSLCO1C1 in gastric cancer progression and resistance to oxaliplatin therapy

BACKGROUND: Gastric carcinoma (GC) is one of the most deadly diseases due to tumour metastasis and resistance to therapy. Understanding the molecular mechanism of tumour progression and drug resistance will improve therapeutic efficacy and develop novel intervention strategies. METHODS: Differential...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yu‐Feng, Li, Bo‐Sheng, Liu, Jing‐Jing, Wang, Su‐Min, Liu, Jiao, Yang, Huan, Hu, Yi‐Yang, Gong, Chun‐Li, Li, Ji‐Liang, Yang, Shi‐Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043116/
https://www.ncbi.nlm.nih.gov/pubmed/35474446
http://dx.doi.org/10.1002/ctm2.691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043116/
https://www.ncbi.nlm.nih.gov/pubmed/35474446
http://dx.doi.org/10.1002/ctm2.691

Ejemplares similares